Pharmaceutical

Northwestern and Case Western Reserve universities develop Huntington’s therapy

Researchers from Northwestern and Case Western Reserve universities have developed a polymer therapeutic to treat Huntington's disease.

Nov 5, 2024 - 06:00
Northwestern and Case Western Reserve universities develop Huntington’s therapy
Researchers from Northwestern and Case Western Reserve universities have developed a polymer therapeutic to treat Huntington's disease.
Read the original article

Tags:

Previous Article

FDA grants fast track status to FELIQS’s FLQ-101 to prevent ROP

Next Article

AstraZeneca’s Obesity Pill Shows Positive Results in Early Trial

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

EpiBiologics names Ann Lee-Karlon as CEO and president

EpiBiologics names Ann Lee-Karlon as CEO and president

Jul 21, 2023

STAT+: Pharmalittle: How 98 days may cost J&J big bucks; Walgreens CEO departs

STAT+: Pharmalittle: How 98 days may cost J&J big bucks...

Sep 2, 2023

STAT+: FDA OKs — but doesn’t require — a non-cancer-causing chemical for sterilizing devices

STAT+: FDA OKs — but doesn’t require — a non-cancer-cau...

Jan 24, 2024